Clearline Capital’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Clearline Capital’s Portfolio PTVE Stock Details PTVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-204,264	Closed	-$3.68M	–	146
2025 Q1	$3.68M	Hold	204,264	–	–	0.22%	69
2024 Q4	$3.57M	Buy	204,264 +36,706	+22%	+$496K	0.47%	55
2024 Q3	$1.93M	Buy	167,558 +22,569	+16%	+$259K	0.08%	97
2024 Q2	$1.64M	Hold	144,989	–	–	0.05%	98
2024 Q1	$2.08M	Buy	+144,989	New	+$2.06M	0.1%	84
2022 Q2	–	Sell	-162,508	Closed	-$1.64M	–	154
2022 Q1	$1.64M	Buy	+162,508	New	+$1.73M	0.19%	84

Clearline Capital's PTVE Position: Q2 2025 in Review

Clearline Capital sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2025, closing a stake of 204,264 shares — an estimated $3.68M sold.

Clearline Capital first reported a position in PTVE in Q1 2022 and held it in 6 quarters. The position peaked at $3.68M in Q1 2025. 0 funds tracked by Wall St. Rank hold PTVE as of Q2 2025.

Clearline Capital reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2025 after selling out during the quarter.
Clearline Capital sold 204,264 Pactiv Evergreen Inc. Common stock shares in Q2 2025, an estimated $3.68M.
Clearline Capital first reported a position in Pactiv Evergreen Inc. Common stock in Q1 2022 and held it in 6 quarters.
Clearline Capital's Pactiv Evergreen Inc. Common stock position peaked at $3.68M in Q1 2025.
0 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2025.

Based on Clearline Capital's 13F filing for Q2 2025, filed 14 Aug 2025.